Article
Biologic properties of endothelial progenitor cells and their potential for cell therapy.
Progress in cardiovascular diseases - 1 Jan 2000
Young Pampee P, Vaughan Douglas E, Hatzopoulos Antonis K
Abstract excerpt
Recent studies indicate that portions of ischemic and tumor neovasculature are derived by neovasculogenesis, whereby bone marrow (BM)-derived circulating endothelial progenitor cells (EPCs) home to sites of regenerative or malignant growth and contribute to blood vessel formation. Recent data from animal models suggest that a variety of cell types, including unfractionated BM mononuclear cells and those obtained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
